oa Levonorgestrel-Releasing Intrauterine System (LNG-IUS) as a Therapy for Endometrial Carcinoma

References

1.   Levonorgestrel intro-uterine system for menorrhagio. Drug Ther Bull. 2001; 39::85–87.
   [Google الباحث العلمي]
2. Abu J, Brown L, Ireland D. Endometrial adenocarcinoma following insertion of the levonorgestrel - Releasing intra-uterine system (Mirena) in a 36 year old woman. Inter J Gyn Cancer. 2006; 16::1439–1478.
   [Google الباحث العلمي]
3. Theodoros G, Simon BM, Anil T. Levonorgestrel releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma. Gynecol Oncol. 2004; 95::762–764.
   [Google الباحث العلمي]
4. Martin-Hirch PL, Jarvis G. Progestogens for endometrial cancer (Cochran Review) In: The Cochrane Library. 2004; Issue 2.
5. Phillips V, Graham CT. The effects of the Levonorgestrel intrauterine system (Mirena Coil) on endometrial morphology.
6. Nilsson CG, Houkkamaa M. Tissue concentrations of Levonorgestrel in women using a Levonorgestrel IUD. Clin Endocrinol. 1982; 17::529–536.
   [Google الباحث العلمي]
7. Anderson JK, Rybo G. Levonorgestrel releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynecol. 1990; 97::690–694.
   [Google الباحث العلمي]
8. Hurskainen R, Paavonen J. Levonorgestrel releasing intrauterine system in the treatment of heavy menstrual bleeding. CurrOpin Obstet Gynecol. 2004; 16::487–490.
   [Google الباحث العلمي]
9. Hurskainen R, Teperi J, Aalto AM. Levonorgestrel releasing intrauterine system or hysterectomy in the treatment of essential menorrhagia: predictors of outcome'Acta Obstet Gynaecol. Scand. 2004; 83::401–403.
   [Google الباحث العلمي]
10. Critchley HO, Wang H, Jones RL. Morphological and functional features of endometrial decidualization following long- term intrauterine levonorgestrel delivery. Hum Reprod. 1998; 13::1218–1224.
    [Google الباحث العلمي]
11. Maruo T, Ladag-Fernandez JB, Pakarinen P. Effects of the Levonorgestrel releasing intrauterine system on proliferation and apoptosis in the endometrium. Hum Reprod. 2001; 16::2103–2108.
    [Google الباحث العلمي]
12. Zalel Y, Shulman A, Lidor A. The local progestational effect of the Levonorgestrel releasing intrauterine system: a sonographic and Doppler flow study. Human Reprod. 2002; 17::2878–2880.
    [Google الباحث العلمي]
13. Bahamondes L, Ribeiro-Huguet P, de Andrade KC. Levonorgestrel releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma. Acta Obstet Gynecol Scand. 2003; 82::580–582.
    [Google الباحث العلمي]
14. Grander FJ, Konje JC, Abrams KR. Endometrial protection from tamoxifen stimulated changes by a Levonorgestrel releasing intrauterine system: A randomized controlled trial. Lancet. 2000; 356::1711–1717.
    [Google الباحث العلمي]
15. Vereide AB, Ames M, Straume B. Nuclear morphometric changes and therapy monitoring in patients with endometrial (hyperplasia: A study comparing effects of intrauterine levonorgestrel and systemic medroxyprogestrone. Gynecol Oncol. 2003; 91:3:526–533.
    [Google الباحث العلمي]
16. References from up to date [1] Endometrial cancer: Clinical features, diagnosis, and screening, [46], page 24 of 33.
17. References from up to date [11,12] Endometrial cancer: Clinical features, diagnosis,and screening, page 3 of 33.
18. From clinics in obstetrics and gynecology [13], December 1986, endometrial cancer, WTCREASMAN, page 690-691.